Top

Published in:

01-09-2014 | Topic Review

Through the patient’s eyes: an emphasis on patient-centered values in operative decision making in the management of malignant glioma

Authors: Adam M. Robin, Steven N. Kalkanis, Jack Rock, Ian Lee, Mark L. Rosenblum

Published in: Journal of Neuro-Oncology | Issue 3/2014

Abstract

The Joint Section on Tumors of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons is now in its 30th year. In many ways its growth and development has paralleled neurosurgery and medicine as a whole. This is most evident in our endeavor towards more patient-centered care and focus on quantity and quality of life. As the push towards evidence-based care continues, it is important to ensure that individualized care remains a guiding principle. Conscientious surgeons continue to refine techniques and develop technologies that push the boundaries of surgical efficacy while better defining the risks of surgery and the impacts of surgical complications. This article provides a review of the factors involved in minimizing risk and obtaining maximal outcomes for patients through insightful patient selection and evidence-based surgical decision-making. Herein, we present the philosophy and practice of the Hermelin Brain Tumor Center at the Henry Ford Health System as one type of approach to caring for the patient with a malignant glioma.

Knapp PC (1891) The pathology, diagnosis and treatment of intra-cranial growths. Rockwell & Churchill, Boston

Knapp PC (1891) A contribution from brain surgery to the study of the localization of the sensory centres in the cerebral cortex. Boston Med Surg J 125:430–433CrossRef

Sanai N, Berger MS (2012) Recent surgical management of gliomas. Adv Exp Med Biol 746:12–25PubMedCrossRef

Sanai N, Polley M-Y, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3–8PubMedCrossRef

Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198PubMedCrossRef

Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen H-J, ALA-Glioma Study Group (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–401CrossRef

Stummer W, van den Bent MJ, Westphal M (2011) Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion. Acta Neurochir (Wien) 153:1211–1218CrossRef

McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A (2009) Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65:463–469; discussion 469–470

Yong RL, Lonser RR (2011) Surgery for glioblastoma multiforme: striking a balance. World Neurosurg 76:528–530PubMedCrossRefPubMedCentral

10.

Gulati S, Jakola AS, Nerland US, Weber C, Solheim O (2011) The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma. World Neurosurg 76:572–579PubMedCrossRef

11.

Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, Wildrick DM (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42:1044–1055; discussion 1055–1056

12.

Chang SM, Parney IF, McDermott M et al (2003) Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98:1175–1181PubMedCrossRef

13.

Kreth FW, Warnke PC, Scheremet R, Ostertag CB (1993) Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg 78:762–766PubMedCrossRef

14.

Mehdorn HM, Schwartz F, Dawirs S, Hedderich J, Dörner L, Nabavi A (2011) High-field iMRI in glioblastoma surgery: improvement of resection radicality and survival for the patient? Acta Neurochir Suppl (Wien) 109:103–106CrossRef

15.

Keles GE, Anderson B, Berger MS (1999) The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 52:371–379PubMedCrossRef

16.

Barker FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB (1998) Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42:709–720; discussion 720–723

17.

Ciric I, Ammirati M, Vick N, Mikhael M (1987) Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery 21:21–26PubMedCrossRef

18.

Eyüpoglu IY, Buchfelder M, Savaskan NE (2013) Surgical resection of malignant gliomas-role in optimizing patient outcome. Nat Rev Neurol 9:141–151PubMedCrossRef

19.

Pichlmeier U, Bink A, Schackert G, Stummer W, ALA Glioma Study Group (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro-Oncol 10:1025–1034CrossRef

20.

Van den Bent MJ, Stupp R, Mason WP, Mirimanoff R, Lacombe D, Gorlia T Impact of extent of resection on overall survival in newly-diagnosed glioblastoma after chemo-irradiation with temozolomide: further analysis of EORTC study 26981 (abstract)

21.

Vuorinen V, Hinkka S, Färkkilä M, Jääskeläinen J (2003) Debulking or biopsy of malignant glioma in elderly people—a randomised study. Acta Neurochir (Wien) 145:5–10CrossRef

22.

McGirt MJ, Chaichana KL, Gathinji M et al (2009) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110:156–162PubMedCrossRef

23.

Duffau H, Mandonnet E (2013) The “onco-functional balance” in surgery for diffuse low-grade glioma: integrating the extent of resection with quality of life. Acta Neurochir (Wien) 155:951–957CrossRef

24.

Díaz JL, Barreto P, Gallego JM, Barbero J, Bayés R, Barcia JA (2009) Proper information during the surgical decision-making process lowers the anxiety of patients with high-grade gliomas. Acta Neurochir (Wien) 151:357–362CrossRef

25.

Laws ER, Parney IF, Huang W et al (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99:467–473PubMedCrossRef

26.

Glantz MJ, Burger PC, Herndon JE 2nd, Friedman AH, Cairncross JG, Vick NA, Schold SC Jr (1991) Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 41:1741–1744PubMedCrossRef

27.

Stendel R (2009) Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 64:E1206; author reply E1206

28.

De Witt Hamer PC, Hendriks EJ, Mandonnet E, Barkhof F, Zwinderman AH, Duffau H (2013) Resection probability maps for quality assessment of glioma surgery without brain location bias. PLoS ONE 8:e73353PubMedCrossRefPubMedCentral

29.

Wilson C (1990) Glioblastoma: the past, the present, and the future. Clinical Neurosurgery. Williams & Wilkins, Los Angeles

30.

Earnest F 4th, Kelly PJ, Scheithauer BW et al (1988) Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166:823–827PubMedCrossRef

31.

Kim EY, Yechieli R, Kim JK et al (2014) Patterns of failure after radiosurgery to two different target volumes of enhancing lesions with and without FLAIR abnormalities in recurrent glioblastoma multiforme. J Neurooncol 116:291–297PubMedCrossRef

32.

Orringer DA, Golby A, Jolesz F (2012) Neuronavigation in the surgical management of brain tumors: current and future trends. Expert Rev Med Devices 9:491–500PubMedCrossRefPubMedCentral

33.

Narang J, Jain R, Arbab AS et al (2011) Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion. Neuro-Oncol 13:1037–1046PubMedCrossRefPubMedCentral

34.

Jolesz FA, Kikinis R, Talos IF (2001) Neuronavigation in interventional MR imaging. Frameless stereotaxy. Neuroimaging Clin N Am 11:685–693, ix

35.

Hartkens T, Hill DLG, Castellano-Smith AD et al (2003) Measurement and analysis of brain deformation during neurosurgery. IEEE Trans Med Imaging 22:82–92PubMedCrossRef

36.

Zakhary R, Keles GE, Berger MS (1999) Intraoperative imaging techniques in the treatment of brain tumors. Curr Opin Oncol 11:152–156PubMedCrossRef

37.

Nimsky C, Ganslandt O, Tomandl B, Buchfelder M, Fahlbusch R (2002) Low-field magnetic resonance imaging for intraoperative use in neurosurgery: a 5-year experience. Eur Radiol 12:2690–2703PubMed

38.

Schackert G, Steinmetz A, Meier U, Sobottka SB (2001) Surgical management of single and multiple brain metastases: results of a retrospective study. Onkologie 24:246–255PubMedCrossRef

39.

Sanai N, Berger MS (2008) Mapping the horizon: techniques to optimize tumor resection before and during surgery. Clin Neurosurg 55:14–19PubMed

40.

Sanai N, Mirzadeh Z, Berger MS (2008) Functional outcome after language mapping for glioma resection. N Engl J Med 358:18–27PubMedCrossRef

41.

Duffau H, Capelle L, Sichez N, Denvil D, Lopes M, Sichez J-P, Bitar A, Fohanno D (2002) Intraoperative mapping of the subcortical language pathways using direct stimulations an anatomo-functional study. Brain 125:199–214PubMedCrossRef

42.

Duffau H, Capelle L, Denvil D et al (2003) Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. J Neuros 98:764–778CrossRef

43.

Sanai N, Eschbacher J, Hattendorf G, Coons SW, Preul MC, Smith KA, Nakaji P, Spetzler RF (2011) Intraoperative confocal microscopy for brain tumors: a feasibility analysis in humans. Neurosurgery 68:282–290; discussion 290

44.

Mohammadi AM, Schroeder JL (2014) Laser interstitial thermal therapy in treatment of brain tumors—the NeuroBlate system. Expert Rev Med Devices 11:109–119PubMedCrossRef

45.

Stafford RJ, Fuentes D, Elliott AA, Weinberg JS, Ahrar K (2010) Laser-induced thermal therapy for tumor ablation. Crit Rev Biomed Eng 38:79–100PubMedCrossRef

46.

Carpentier A, Chauvet D, Reina V et al (2012) MR-guided laser-induced thermal therapy (LITT) for recurrent glioblastomas. Lasers Surg Med 44:361–368PubMedCrossRef

47.

Kalkanis SN, Kast RE, Rosenblum ML et al (2014) Raman spectroscopy to distinguish grey matter, necrosis, and glioblastoma multiforme in frozen tissue sections. J Neurooncol 116:477–485PubMedCrossRef

48.

Kircher MF, de la Zerda A, Jokerst JV et al (2012) A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat Med 18:829–834PubMedCrossRefPubMedCentral

Title: Through the patient’s eyes: an emphasis on patient-centered values in operative decision making in the management of malignant glioma
Authors: Adam M. Robin
Steven N. Kalkanis
Jack Rock
Ian Lee
Mark L. Rosenblum
Publication date: 01-09-2014
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 3/2014
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-014-1492-4

At a glance: The STEP trials

Springer Medicine

Through the patient’s eyes: an emphasis on patient-centered values in operative decision making in the management of malignant glioma

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Advances in genetic and epigenetic analyses of gliomas: a neuropathological perspective

Clinical trials in neurosurgical oncology

Unyielding progress: recent advances in the treatment of central nervous system neoplasms with radiosurgery and radiation therapy

Through the patient’s eyes: the value of a comprehensive brain tumor center

Vaccine therapies for patients with glioblastoma

Clinical practice guidelines in the AANS/CNS Section on Tumors: past, present and future directions